MYL Mylan NV

As filed with the Securities and Exchange Commission on September 14, 2015

Registration No. 333-          

 

 

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

 

Form S-8

REGISTRATION STATEMENT

UNDER

THE SECURITIES ACT OF 1933

 

 

Mylan N.V.

(Exact name of registrant as specified in its charter)

 

 

 

The Netherlands		2834		98-1189497
(State or other jurisdiction of incorporation or organization)		(Primary Standard Industrial Classification Code Number)		(I.R.S. Employer Identification Number)

Building 4, Trident Place

Mosquito Way, Hatfield

Hertfordshire, AL10 9UL England

Tel: +44 (0) 1707-853-000

(Address, including zip code, and telephone number, including

area code, of registrant’s principal executive offices)

Mylan N.V. Amended and Restated 2003 Long-Term Incentive Plan (formerly Mylan Inc. Amended and Restated 2003 Long-Term Incentive Plan)

(Full Title of Plans)

John D. Sheehan

Executive Vice President and

Chief Financial Officer

Mylan N.V.

c/o Mylan Inc.

1000 Mylan Boulevard

Canonsburg, Pennsylvania 15317

Tel: (724) 514-1800

(Name, address, and telephone number, including area code, of agent for service)

 

 

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, or a smaller reporting company. See the definitions of “large accelerated filer,” “accelerated filer,” and “smaller reporting company” in Rule 12b-2 of the Securities Exchange Act of 1934, as amended (Check one):

 

Large accelerated filer		x		Accelerated filer		¨
Non-accelerated filer		¨  (Do not check if a smaller reporting company)		Smaller reporting company		¨

 

 

CALCULATION OF REGISTRATION FEE

 

Title of each class of securities to be registered		Amount to be registered(1)(2)		Proposed maximum offering price per share(3)		Proposed maximum aggregate offering price(3)		Amount of registration fee(4)
Ordinary shares, nominal value €0.01 per share		26,078,580		N/A		$1,112,098,492.26		$68,415.46

(1)

Represents 7,590,573 ordinary shares of Mylan N.V. (the “Registrant”) to be issued pursuant to the exercise of outstanding stock options granted to participants under the Mylan N.V. Amended and Restated 2003 Long Term Incentive Plan (the “Plan”) and 18,488,007 ordinary shares of the Registrant subject to outstanding equity-based awards other than stock options or that remain available for issuance under the Plan.

(2)

Pursuant to Rule 416(a) under the Securities Act of 1933, as amended (the “Securities Act”), this Registration Statement also covers an indeterminate number of additional ordinary shares as may be offered or issued under the Plan pursuant to this Registration Statement by reason of any stock split, stock dividends, or similar transactions or any other anti-dilutive or adjustment provisions of the Plan, as applicable.

(3)

Estimated solely for purposes of calculating the registration fee pursuant to Rule 457(h)(1) under the Securities Act. With respect to the ordinary shares subject to outstanding equity-based awards other than stock options or that remain available for issuance under the Plan, pursuant to Rule 457(h)(1), the proposed maximum offering price per share and proposed maximum aggregate offering price are based on the average of the high and low prices of our ordinary shares on the NASDAQ Global Select Market on September 4, 2015. With respect to the 7,590,573 ordinary shares issuable pursuant to outstanding but unexercised stock options previously granted under the Plan, pursuant to Rule 457(h)(1) of the Securities Act, the proposed maximum offering price per share and proposed maximum aggregate offering price are based on the weighted average exercise price of such shares of $30.89.

(4)

Pursuant to Rule 457(p) of the Securities Act, the currently due registration fee for this Registration Statement is being offset by $60,810.38 in filing fees paid in connection with unsold securities under the registration statement on Form S-8 (File No. 333-202348) filed by the Registrant on February 27, 2015 and the registration statement on Form S-8 (File No. 333-186933) filed by the Registrant’s wholly owned subsidiary, Mylan Inc., on February 28, 2013.

 

 

 

---

Explanatory Note

This Registration Statement on Form S-8 (the “Registration Statement”) is being filed by Mylan N.V. (the “Registrant”), a public limited liability company (naamloze vennootschap) organized and existing under the laws of the Netherlands, as successor registrant to Mylan Inc. (“Predecessor”), a Pennsylvania corporation, with the Securities and Exchange Commission (the “Commission”) for the purpose of registering 26,078,580 of the Registrant’s ordinary shares, nominal value €0.01 per share, for issuance pursuant to the Mylan N.V. Amended and Restated 2003 Long-Term Incentive Plan (the “Plan”). On February 9, 2015, the Board of Directors and the shareholder of the Registrant approved the assumption of the Plan by the Registrant.

Part I

Information Required in the Section 10(a) Prospectus

 

Item 1.

Plan Information.

The documents containing the information specified in Part I will be sent or given to employees participating in the Plan, as specified by Rule 428(b)(1) promulgated under the Securities Act of 1933, as amended (the “Securities Act”). In accordance with the instructions to Part I of Form S-8, such documents will not be filed with the Commission either as part of this Registration Statement or as prospectuses or prospectus supplements pursuant to Rule 424 promulgated under the Securities Act. These documents and the documents incorporated by reference pursuant to Item 3 of Part II of this Registration Statement, taken together, constitute the prospectus as required by Section 10(a) of the Securities Act.

 

Item 2.

Registrant Information and Plan Annual Information.

Upon written or oral request, any of the documents incorporated by reference in Item 3 of Part II of this Registration Statement (which documents are incorporated by reference in the Section 10(a) prospectus), any other document required to be delivered to eligible participants pursuant to Rule 428(b) or additional information about the Plan is available without charge by contacting:

Mylan N.V.

Building 4, Trident Place

Mosquito Way, Hatfield

Hertfordshire, AL10 9UL England

Tel: +44 (0) 1707-853-000

 

1

---

Part II

Information Required in the Registration Statement

 

Item 3.

Incorporation of Documents by Reference.

The following documents filed by the Registrant and Predecessor with the Commission pursuant to the Securities Exchange Act of 1934, as amended (the “Exchange Act”) (other than information furnished pursuant to Item 2.02 or Item 7.01 of a Current Report on Form 8-K), are incorporated by reference into, and shall be deemed to be a part of, this Registration Statement:

 

1.

Predecessor’s Annual Report on Form 10-K for the fiscal year ended December 31, 2014, filed on March 2, 2015 (amended April 30, 2015);

 

2.

Registrant’s Quarterly Reports on Form 10-Q for the three months ended June 30, 2015, filed on August 6, 2015, and for the three months ended March 31, 2015, filed on May 8, 2015;

 

3.

Registrant’s Current Reports on Form 8-K filed on February 27, 2015 (amended March 26, 2015), February 27, 2015, April 3, 2015, April 6, 2015, April 8, 2015, April 24, 2015, April 29, 2015, May 1, 2015, May 7, 2015, June 1, 2015, June 8, 2015, June 11, 2015, June 15, 2015, June 19, 2015, July 21, 2015, July 23, 2015, July 27, 2015, July 27, 2015, August 6, 2015, August 7, 2015 and September 2, 2015;

 

4.

Registrant’s Proxy Statement on Schedule 14A filed on July 28, 2015;

 

5.

Predecessor’s Proxy Statements on Schedule 14A filed on December 24, 2014 and March 10, 2014; and

 

6.

Registrant’s Registration Statement on Form S-4/A filed with the SEC on September 9, 2015.

All documents subsequently filed by the Registrant and/or its predecessor with the Commission pursuant to Sections 13(a), 13(c), 14 and 15(d) of the Exchange Act (other than information furnished pursuant to Item 2.02 or Item 7.01 of a Current Report on Form 8-K), after the date of this Registration Statement, but prior to the filing of a post-effective amendment to this Registration Statement which indicates that all securities offered hereby have been sold or which deregisters all securities then remaining unsold, shall be deemed to be incorporated by reference into this Registration Statement. Each document incorporated or deemed incorporated by reference into this Registration Statement shall be deemed to be a part of this Registration Statement from the date of the filing of such document with the Commission until the information contained therein is superseded or updated by any subsequently filed document which is incorporated or deemed incorporated by reference into this Registration Statement or by any document which constitutes a part of the prospectus relating to the Plan meeting the requirements of Section 10(a) of the Securities Act. Any such information so modified or superseded shall not be deemed, except as so modified or superseded, to constitute part of this Registration Statement.

 

Item 4.

Description of Securities.

The class of securities to be offered under this Registration Statement is registered under Section 12(b) of the Exchange Act.

 

Item 5.

Interests of Named Experts and Counsel.

Not applicable.

 

Item 6.

Indemnification of Directors and Officers.

Without prejudice to any indemnity to which such person may be contractually or otherwise entitled and to the fullest extent permitted by applicable Dutch law, as the same exists or may be amended (but, in the case of such amendment, only to the extent that such amendment permits the Registrant to provide broader indemnification rights than such law permitted the Registrant to provide prior to such amendment), the Registrant’s articles of association (the “Articles”) provide that the Registrant will indemnify any director or officer who was, is, or becomes in his or her capacity as director or officer a party or witness or is or becomes threatened to be made a party or witness to any threatened, pending, or completed action, suit, or proceeding, whether civil, criminal, or administrative or any action, suit, or proceeding in order to obtain information, against any and all liabilities including all expenses (including attorneys’ fees), judgments, fines, amounts paid in settlement, and other financial losses, actually and reasonably incurred by him or her in connection with such action, suit, or proceeding.

Under Dutch law, indemnification generally may not be available to any person in respect of any claim, issue, or matter as to which such person will have been adjudged in a final and non-appealable judgment by a Dutch or other court of competent

 

2

---

jurisdiction to be liable for intentional recklessness or willful misconduct in the performance of his or her duty to the Registrant unless such court determines that such person is fairly and reasonably entitled to such indemnification despite the adjudication of such liability, or to the extent any related costs and losses have been insured and reimbursed to such person under any applicable insurance policy. Also, indemnification may not be available in respect of any claim brought by the Registrant and for which the person is adjudged in a final and non-appealable judgment to be liable to the Registrant unless the court or the Registrant shall have determined that indemnification of some or all expenses incurred by such person is appropriate and permitted under applicable law.

The Registrant also has entered into indemnification agreements with each of its directors and certain of its officers that provide them with substantially similar indemnification rights to those provided under the Registrant’s Articles.

The Articles also provide that the Registrant may maintain an insurance policy which insures directors and officers against certain liabilities which might be incurred in connection with the performance of their duties. The Registrant currently maintains such a policy. The description of indemnity herein is merely a summary of the provisions in the Articles and other indemnification agreements, and such description shall not limit or alter the provisions in the Articles or other indemnification agreements. The Shareholder Agreement dated as of February 27, 2015, among the Registrant, Abbott Laboratories (“Abbott”) and the Abbott subsidiaries named therein, provides for indemnification of the Registrant and its directors and officers by Abbott and such Abbott subsidiaries, and of Abbott and such Abbott subsidiaries and their respective directors and officers by the Registrant, against certain liabilities.

 

Item 7.

Exemption From Registration Claimed.

Not applicable.

 

Item 8.

Exhibits.

The following exhibits are filed herewith as part of this Registration Statement.

 

Exhibit No.		Description
4.1		Registrant’s Articles of Association, filed as Exhibit 3.1 to the Registrant’s Current Report on Form 8-K filed on February 27, 2015, and incorporated herein by reference.
4.2		Shareholder Agreement, filed as Exhibit 2.2 to the Registrant’s Current Report on Form 8-K filed on February 27, 2015, and incorporated by reference herein.
5.1		Opinion of NautaDutilh N.V. regarding the legality of the ordinary shares of the Registrant.
23.1		Consent of NautaDutilh N.V. (included in the legal opinion filed as Exhibit 5.1).
23.2		Consent of Deloitte & Touche LLP, independent registered public accounting firm.
23.3		Consent of Deloitte & Touche LLP, independent auditor.
23.4		Consent of Ernst & Young LLP, independent auditor.
24.1		Power of Attorney (included on the signature page of this Registration Statement).
99.1		Mylan Inc. Amended and Restated 2003 Long-Term Incentive Plan (incorporated by reference to Exhibit 10.4(a) to Predecessor’s Form 10-K for the fiscal year ended December 31, 2012, and incorporated herein by reference).

 

Item 9.

Undertakings.

(a) The undersigned Registrant hereby undertakes:

(1) To file, during any period in which offers or sales are being made, a post-effective amendment to this Registration Statement:

(i) To include any prospectus required by Section 10(a)(3) of the Securities Act;

(ii) To reflect in the prospectus any facts or events arising after the effective date of this Registration Statement (or the most recent post-effective amendment thereof) which, individually or in the aggregate, represent a fundamental

 

3

---

change in the information set forth in this Registration Statement. Notwithstanding the foregoing, any increase or decrease in volume of securities offered (if the total dollar value of securities offered would not exceed that which was registered) and any deviation from the low or high end of the estimated maximum offering range may be reflected in the form of prospectus filed with the Commission pursuant to Rule 424(b) if in the aggregate, the changes in volume and price represent no more than 20% change in the maximum aggregate offering price set forth in the “Calculation of Registration Fee” table in this effective Registration Statement; and

(iii) To include any material information with respect to the plan of distribution not previously disclosed in this Registration Statement or any material change to such information in this Registration Statement; however, that paragraphs (a)(1)(i) and (a)(1)(ii) of this section do not apply if the information required to be included in a post-effective amendment by those paragraphs is contained in periodic reports filed with or furnished to the Commission by the Registrant pursuant to Section 13 or Section 15(d) of the Exchange Act that are incorporated by reference in this Registration Statement.

(2) That, for the purpose of determining any liability under the Securities Act, each such post-effective amendment shall be deemed to be a new registration statement relating to the securities offered therein, and the offering of such securities at that time shall be deemed to be the initial bona fide offering thereof.

(3) To remove from registration by means of a post-effective amendment any of the securities being registered which remain unsold at the termination of the offering.

(b) The undersigned Registrant hereby undertakes that, for purposes of determining any liability under the Securities Act, each filing of the Registrant’s annual report pursuant to Section 13(a) or Section 15(d) of the Exchange Act (and, where applicable, each filing of an employee benefit plan’s annual report pursuant to Section 15(d) of the Exchange Act) that is incorporated by reference in this Registration Statement shall be deemed to be a new registration statement relating to the securities offered therein, and the offering of such securities at that time shall be deemed to be the initial bona fide offering thereof.

***

(h) Insofar as indemnification for liabilities arising under the Securities Act may be permitted to directors, officers and controlling persons of the Registrant pursuant to the foregoing provisions, or otherwise, the Registrant has been advised that in the opinion of the Commission such indemnification is against public policy as expressed in the Securities Act and is, therefore, unenforceable. In the event that a claim for indemnification against such liabilities (other than the payment by the Registrant of expenses incurred or paid by a director, officer or controlling person of the Registrant in the successful defense of any action, suit or proceeding) is asserted by such director, officer or controlling person in connection with the securities being registered, the Registrant will, unless in the opinion of its counsel the matter has been settled by controlling precedent, submit to a court of appropriate jurisdiction the question whether such indemnification by it is against public policy as expressed in the Securities Act and will be governed by the final adjudication of such issue.

 

4

---

SIGNATURES

Pursuant to the requirements of the Securities Act of 1933, the Registrant certifies that it has reasonable grounds to believe that it meets all of the requirements for filing on Form S-8 and has duly caused this Registration Statement to be signed on its behalf by the undersigned, thereunto duly authorized, in the City of Pittsburgh, Commonwealth of Pennsylvania, on September 14, 2015.

 

AUTHORIZED REPRESENTATIVE IN THE UNITED STATES

Pursuant to the requirements of the Securities Act of 1933, as amended, the Registrant has duly caused this Registration Statement to be signed by the following duly authorized representative in the United States:

 

Power of Attorney

Each of the undersigned officers and directors of the Registrant, a public limited liability company (naamloze vennootschap) organized and existing under the laws of the Netherlands, hereby constitutes and appoints, John D. Sheehan, and each of them, as his or her true and lawful attorney-in-fact and agent, severally, with full power of substitution and resubstitution, in his or her name and on his or her behalf, in any and all capacities, to sign any and all amendments (including post-effective amendments) to this Registration Statement, and to file the same, with all exhibits thereto and all documents in connection therewith, with the Securities and Exchange Commission, granting unto said attorneys-in-fact and agents, and each of them, full power of authority to do and perform each and every act and thing requisite or necessary to be done in and about the premises, as fully to all intents and purposes as he or she might or could do in person, thereby ratifying and confirming all that said attorneys-in-fact and agents, or their substitutes, may lawfully do or cause to be done.

Pursuant to the requirements of the Securities Act of 1933, this Registration Statement has been signed by the following persons in the capacities and on the dates indicated.

 

Signature		Title		Date
/s/ Robert J. Coury Robert J. Coury		Non-Executive Director and Executive Chairman of the Board		September 14, 2015
/s/ Heather Bresch Heather Bresch		Chief Executive Officer and Executive Director (Principal Executive Officer)		September 14, 2015
/s/ John D. Sheehan John D. Sheehan		Executive Vice President and Chief Financial Officer (Principal Financial Officer and Accounting Officer)		September 14, 2015
/s/ Rodney L. Piatt Rodney L. Piatt		Non-Executive Director, Lead Independent Director and Vice Chairman of the Board		September 14, 2015

 

5

---

/s/ Wendy Cameron Wendy Cameron		Non-Executive Director		September 14, 2015
/s/ Robert J. Cindrich Robert J. Cindrich		Non-Executive Director		September 14, 2015
/s/ JoEllen Lyons Dillon JoEllen Lyons Dillon		Non-Executive Director		September 14, 2015
/s/ Neil F. Dimick Neil F. Dimick		Non-Executive Director		September 14, 2015
/s/ Melina Higgins Melina Higgins		Non-Executive Director		September 14, 2015
/s/ Douglas J. Leech Douglas J. Leech		Non-Executive Director		September 14, 2015
/s/ Rajiv Malik Rajiv Malik		President and Executive Director		September 14, 2015
/s/ Joseph C. Maroon, M.D. Joseph C. Maroon, M.D.		Non-Executive Director		September 14, 2015
/s/ Mark W. Parrish Mark W. Parrish		Non-Executive Director		September 14, 2015
/s/ R.L. Vanderveen, Ph.D., R. Ph. R.L. Vanderveen, Ph.D., R. Ph.		Non-Executive Director		September 14, 2015

 

6

---

Exhibit Index

 

Exhibit No.		Description
4.1		Registrant’s Articles of Association, filed as Exhibit 3.1 to the Registrant’s Current Report on Form 8-K filed on February 27, 2015, and incorporated herein by reference.
4.2		Shareholder Agreement, filed as Exhibit 2.2 to the Registrant’s Current Report on Form 8-K filed on February 27, 2015, and incorporated by reference herein.
5.1		Opinion of NautaDutilh N.V. regarding the legality of the ordinary shares of the Registrant.
23.1		Consent of NautaDutilh N.V. (included in the legal opinion filed as Exhibit 5.1).
23.2		Consent of Deloitte & Touche LLP, independent registered public accounting firm.
23.3		Consent of Deloitte & Touche LLP, independent auditor.
23.4		Consent of Ernst & Young LLP, independent auditor.
24.1		Power of Attorney (included on the signature page of this Registration Statement).
99.1		Mylan Inc. Amended and Restated 2003 Long-Term Incentive Plan (incorporated by reference to Exhibit 10.4(a) to Predecessor’s Form 10-K for the fiscal year ended December 31, 2012, and incorporated herein by reference).

 

7

Exhibit 5.1

 

 

ADVOCATEN • NOTARISSEN • BELASTINGADVISEURS

 

P.O. Box 7113 1007 JC Amsterdam Strawinskylaan 1999 1077 XV Amsterdam T +31 20 71 71 000 F +31 20 71 71 111		Amsterdam, 14 September 2015   To:   Mylan N.V. (the “Company”) Building 4 Trident Place, Mosquito Way Hatfield, Hertfordshire AL10 9UL, England

Ladies and Gentlemen:

SEC Exhibit 5.1 opinion letter

We have acted as your legal counsel as to Netherlands law, and are rendering this opinion letter to you, in connection with the filing by the Company of a registration statement on Form S-8 (the “Registration Statement”) with the U.S. Securities and Exchange Commission (the “SEC”) in connection with the registration of 26,078,580 ordinary shares in the Company’s capital with a nominal value of €0.01 each (the “Plan Shares”) that may be issued under the Plan (as defined below).

This opinion letter is addressed solely to you. It may only be relied upon in connection with the Registration Statement. This opinion letter is strictly limited to the matters stated in it and may not be read as extending by implication to any matters not specifically referred to in it. Nothing in this opinion letter should be taken as expressing an opinion in respect of any representations or warranties, or other information, contained in any document.

In rendering the opinions expressed in this opinion letter, we have reviewed and relied upon the following documents:

 

(i)	a pdf copy of the deed of incorporation (akte van oprichting) of the Company, dated 7 July 2014 (“Deed of Incorporation”);

 

(ii)	a pdf copy of the deed of conversion (akte van omzetting) of the Company, dated 27 February 2015 (“Deed of Conversion”);

 

(iii)

a pdf copy of the continuous text of the articles of association of the Company as they read after the execution of a deed of amendment to the articles of association of the Company, dated 27 February 2015 (the “Articles of Association”);

 

This communication is confidential and may be subject to professional privilege. All legal relationships are subject to NautaDutilh N.V.‘s general terms and conditions (see www.nautadutilh.com/terms), which apply mutatis mutandis to our relationship with third parties relying on statements of NautaDutilh N.V., include a limitation of liability clause, have been filed with the Rotterdam District Court and will be provided free of charge upon request. NautaDutilh N.V.; corporate seat Rotterdam; trade register no. 24338323.

---

 

2

 

(iv)	copies of the minutes of the meeting of the Company’s board of directors (bestuur) held on 9 February 2015;

 

(v)	copies of the written resolution of the general meeting of shareholders of the Company adopted on 9 February 2015 (together with the resolutions recorded in the documents referred to under (iv), the “Resolutions”);

 

(vi)	a pdf copy of the Company’s Amended and Restated 2003 Long Term Incentive Plan (the “Plan”);

 

(vii)

a pdf copy of the Registration Statement dated 14 September 2015;

 

(viii)

a pdf copy of an extract from the Commercial Register of the Chamber of Commerce (handelsregister van de Kamer van Koophandel) relating to the Company, dated the date of this opinion letter (the “Extract”); and

 

(ix)	a pdf copy of a certificate, dated the date of this opinion letter purported to have been signed by the Assistant Secretary of the Company (the “Certificate”).

This opinion letter sets out our opinion on certain matters of the laws with general applicability of the Netherlands, and, insofar as they are directly applicable in the Netherlands, of the European Union, as at today’s date and as presently interpreted under published authoritative case law of the Netherlands courts, the General Court and the Court of Justice of the European Union. We do not express any opinion on Netherlands or European competition law, regulatory law or tax law. No undertaking is assumed on our part to revise, update or amend this opinion letter in connection with or to notify or inform you of, any developments and/or changes of Netherlands law subsequent to today’s date.

The opinions expressed in this opinion letter are to be construed and interpreted in accordance with Netherlands law. The competent courts at Amsterdam, the Netherlands, have exclusive jurisdiction to settle any issues of interpretation or liability arising out of or in connection with this opinion letter. Any legal relationship arising out of or in connection with this opinion letter (whether contractual or non-contractual), including the above submission to jurisdiction, is governed by Netherlands law and the general terms and conditions of NautaDutilh N.V. Any liability arising out of or in connection with this opinion letter shall be limited to the amount which is paid out under the insurance policy of NautaDutilh N.V. in the matter concerned and no person other than NautaDutilh N.V. may be held liable in connection with this opinion letter.

---

 

3

 

In this opinion letter, legal concepts are expressed in English terms. The Netherlands legal concepts concerned may not be identical in meaning to the concepts described by the English terms as they exist under the law of other jurisdictions. In the event of a conflict or inconsistency, the relevant expression shall be deemed to refer only to the Netherlands legal concepts described by the English terms.

For the purposes of this opinion letter, we have assumed that:

 

a.	drafts of documents reviewed by us shall be in conformity with the executed originals, each copy of a document conforms to the original, each original is authentic, and each signature is the genuine signature of the individual purported to have placed that signature;

 

b.	the Registration Statement has been or shall be filed with the SEC, and shall become effective, in the form referred to in this opinion letter;

 

c.

that any Plan Shares will be issued, offered, sold, delivered, duly accepted and paid by the subscribers pursuant to the exercise of the right of the subscriber, to persons legally entitled to purchase Plan Shares, (a) as contemplated and in accordance with the Plan and the Registration Statement, (b) in accordance with any applicable law (including, without limitation, the laws of the Netherlands), (c) in accordance with the Articles of Association as in force at the date of issuance of such Plan Shares and (d) with such terms so as not to violate any applicable law (including, for the avoidance of doubt, any law applicable at the time of such issue, offer, sale, delivery and acceptance) and upon issue of each Plan Share at least a consideration will be paid to the Company on such Plan Share, or, as the case may be, will be charged from the distributable reserves of the Company, with a value equal to the nominal amount thereof and any premium agreed upon (bedongen agio);

 

d.	that each time a Plan Share is issued, the authorized share capital (maatschappelijk kapitaal) of the Company is such that such Plan Share can be validly issued;

 

e.	each of the assumptions made in this opinion letter will be correct in all aspects by reference to the facts and circumstances existing each time a Plan Share is issued;

 

f.	the statements included in the Certificate are true and correct on the date of this opinion letter and each time a Plan Share is issued; and

---

 

4

 

g.	none of the opinions stated in this opinion letter will be affected by any foreign law.

Based upon and subject to the foregoing and subject to the qualifications set forth in this opinion letter and to any matters, documents or events not disclosed to us, we express the following opinions:

 

1.	The Plan Shares, when issued pursuant to and in accordance with the terms of the Plan, will be validly issued, fully paid and non-assessable.

The opinions expressed above are subject to the following qualifications:

 

A.	The information contained in the Extract does not constitute conclusive evidence of the facts reflected in it.

 

B.

Pursuant to Article 2:7 of the Dutch Civil Code, any transaction entered into by a legal entity may be nullified by the legal entity itself or its liquidator in bankruptcy proceedings (curator) if the purpose of that entity were transgressed by the transaction and the other party to the transaction knew or should have known this without independent investigation (wist of zonder eigen onderzoek moest weten). The Netherlands Supreme Court (Hoge Raad der Nederlanden) has ruled that in determining whether the purpose of a legal entity are transgressed, not only the description of the purpose in that legal entity’s articles of association (statuten) is decisive, but all (relevant) circumstances must be taken into account, in particular whether the interests of the legal entity were served by the transaction. Based on the purpose clause contained in the Articles of Association, we have no reason to believe that by entering into the Deed of Issue the Company would transgress the description of the purpose contained in its Articles of Association. However, we cannot assess whether there are other relevant circumstances that must be taken into account, in particular whether the interests of the Company are served by entering into the Deeds of Issue since this is a matter of fact.

 

C.	The opinions expressed in this opinion letter may be limited or affected by:

 

a.

any applicable bankruptcy, insolvency, reorganisation, moratorium or other similar laws or procedures now or hereinafter in effect, relating to or affecting the enforcement or protection of creditors’ rights generally;

---

 

5

 

b.

the provisions of fraudulent preference and fraudulent conveyance (Actio Pauliana) and similar rights available in other jurisdictions to liquidators in bankruptcy proceedings or creditors;

 

c.

claims based on tort (onrechtmatige daad); and

 

d.

sanctions and measures implemented or effective in the Netherlands under the Sanctions Act 1977 (Sanctiewet 1977), or European Union regulations.

 

D.

As used in the opinions expressed in paragraph 1 of this opinion letter, the term “non-assessable” - which term has no equivalent in Dutch - means that a holder of a share will not by reason of merely being such a holder, be subject to assessment or calls by the Company or its creditors for further payment on such share.

 

E.	This opinion letter does not purport to express any opinion or view on the operational rules and procedures of any clearing or settlement system or agency.

We consent to the filing of this opinion letter as an exhibit to the Registration Statement and also consent to the reference to NautaDutilh N.V. in the Registration Statement under the caption “Legal Matters”.

Sincerely yours,

/s/  NautaDutilh N.V.

NautaDutilh N.V.

Exhibit 23.2

CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM

We consent to the incorporation by reference in this Registration Statement on Form S-8 of Mylan N.V. of our reports dated March 2, 2015 (June 11, 2015 as to Note 14), relating to the consolidated financial statements and consolidated financial statement schedule of Mylan Inc. and subsidiaries (the “Company”), and the effectiveness of the Company’s internal control over financial reporting, appearing in the Current Report on Form 8-K of Mylan N.V. dated June 11, 2015.

/s/ Deloitte & Touche LLP

Pittsburgh, Pennsylvania

September 14, 2015

Exhibit 23.3

CONSENT OF INDEPENDENT AUDITORS

We consent to the incorporation by reference in this Registration Statement of Mylan N.V. on Form S-8 of our report dated October 23, 2014 related to the combined financial statements of The Developed Markets Branded Generics Pharmaceuticals Business of Abbott Laboratories as described in Note 1 to such combined financial statements as of December 31, 2013 and 2012, and for the three years in the period ended December 31, 2013 (which report expresses an unmodified opinion and includes an emphasis-of-matter paragraph relating to expense allocations from the consolidated financial statements and accounting records of Abbott Laboratories), appearing in Mylan Inc.’s Proxy Statement on Schedule 14A for the Special Meeting of Mylan Inc. Shareholders filed December 24, 2014.

/s/ Deloitte & Touche LLP

Chicago, Illinois

September 14, 2015

Exhibit 23.4

Consent of Independent Auditors

We consent to the incorporation by reference in this Registration Statement on Form S-8 pertaining to the Amended and Restated 2003 Long Term Incentive Plan of Mylan N.V. of our report dated March 23, 2015, with respect to the combined financial statements of The Developed Markets Branded Generics Pharmaceuticals Business of Abbott Laboratories as of and for the year ended December 31, 2014 (which report expresses an unmodified opinion and includes an emphasis-of-matter paragraph relating to expense allocations from the consolidated financial statements and accounting records of Abbott Laboratories) included in Mylan N.V.’s Current Report on Form 8-K/A dated March 26, 2015, filed with the Securities and Exchange Commission.

/s/ Ernst & Young LLP

Chicago, Illinois

September 14, 2015